DWA
SRRA

Dorsey Wright & Associates’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Dorsey Wright & Associates’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,500
Closed -$48K – 346
2022
Q1 		$48K Buy
+1,500
New +$43K 0.01% 211

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dorsey Wright & Associates's SRRA Position: Q2 2022 in Review

Dorsey Wright & Associates sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 1,500 shares — an estimated $48K sold.

Dorsey Wright & Associates first reported a position in SRRA in Q1 2022 and held it in 1 quarter. The position peaked at $48K in Q1 2022. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

  • Dorsey Wright & Associates reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,500 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $48K.
  • Dorsey Wright & Associates first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Dorsey Wright & Associates's Sierra Oncology, Inc. Common Stock position peaked at $48K in Q1 2022.
  • 109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on Dorsey Wright & Associates's 13F filing for Q2 2022, filed 20 Jul 2022.